Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Nocentini

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Critical Reviews in Oncology/Hematology|March 1, 1996
Ribonucleotide reductase inhibitors: new strategies for cancer chemotherapyG Nocentini
Biochemical Pharmacology|July 12, 1996
The 2,2'-bipyridyl-6-carbothioamide copper (II) complex differs from the iron (II) complex in its biochemical effects in tumor cells, suggesting possible differences in the mechanism leading to cytotoxicityG Nocentini, A Barzi
General Pharmacology|November 5, 1997
Antitumor activity of 2,2'-bipyridyl-6-carbothioamide: a ribonucleotide reductase inhibitorG Nocentini, A Barzi
Pharmacological Research|September 1, 1990
Implications and problems in analysing cytotoxic activity of hydroxyurea in combination with a potential inhibitor of ribonucleotide reductaseG Nocentini, A Barzi
Arzneimittel-Forschung|December 1, 1995
A predictive screening model for in vitro selection of agents with potential antitumor activityG Nocentini, A Barzi
Cancer Chemotherapy and Pharmacology|January 1, 1990
Implications and problems in analysing cytotoxic activity of hydroxyurea in combination with a potential inhibitor of ribonucleotide reductaseG Nocentini, A Barzi, P Franchetti
Cancer Research|January 1, 1993
2,2'-Bipyridyl-6-carbothioamide and its ferrous complex: their in vitro antitumoral activity related to the inhibition of ribonucleotide reductase R2 subunitG Nocentini, F Federici, P Franchetti, et al.
Anti-Cancer Drugs|December 1, 1990
Isolation of two cellular lines resistant to ribonucleotide reductase inhibitors to investigate the inhibitory activity of 2,2'-bipyridyl-6-carbothioamideG Nocentini, F Federici, R Armellini, et al.
Journal of Medicinal Chemistry|July 1, 1989
3,7-Dideazapurine nucleosides. Synthesis and antitumor activity of 1-deazatubercidin and 2-chloro-2'-deoxy-3,7-dideazaadenosineG Cristalli, P Franchetti, M Grifantini, et al.
International Journal of Immunopathology and Pharmacology|February 11, 2003
Oxidative stress and apoptosis in immune diseasesM. Agostini, B. Di Marco, G. Nocentini, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Critical Reviews in Oncology/Hematology|March 1, 1996
Ribonucleotide reductase inhibitors: new strategies for cancer chemotherapyG Nocentini
Biochemical Pharmacology|July 12, 1996
The 2,2'-bipyridyl-6-carbothioamide copper (II) complex differs from the iron (II) complex in its biochemical effects in tumor cells, suggesting possible differences in the mechanism leading to cytotoxicityG Nocentini, A Barzi
General Pharmacology|November 5, 1997
Antitumor activity of 2,2'-bipyridyl-6-carbothioamide: a ribonucleotide reductase inhibitorG Nocentini, A Barzi
Pharmacological Research|September 1, 1990
Implications and problems in analysing cytotoxic activity of hydroxyurea in combination with a potential inhibitor of ribonucleotide reductaseG Nocentini, A Barzi
Arzneimittel-Forschung|December 1, 1995
A predictive screening model for in vitro selection of agents with potential antitumor activityG Nocentini, A Barzi
Cancer Chemotherapy and Pharmacology|January 1, 1990
Implications and problems in analysing cytotoxic activity of hydroxyurea in combination with a potential inhibitor of ribonucleotide reductaseG Nocentini, A Barzi, P Franchetti
Cancer Research|January 1, 1993
2,2'-Bipyridyl-6-carbothioamide and its ferrous complex: their in vitro antitumoral activity related to the inhibition of ribonucleotide reductase R2 subunitG Nocentini, F Federici, P Franchetti, et al.
Anti-Cancer Drugs|December 1, 1990
Isolation of two cellular lines resistant to ribonucleotide reductase inhibitors to investigate the inhibitory activity of 2,2'-bipyridyl-6-carbothioamideG Nocentini, F Federici, R Armellini, et al.
Journal of Medicinal Chemistry|July 1, 1989
3,7-Dideazapurine nucleosides. Synthesis and antitumor activity of 1-deazatubercidin and 2-chloro-2'-deoxy-3,7-dideazaadenosineG Cristalli, P Franchetti, M Grifantini, et al.
International Journal of Immunopathology and Pharmacology|February 11, 2003
Oxidative stress and apoptosis in immune diseasesM. Agostini, B. Di Marco, G. Nocentini, et al.
Pageof 4